NovoNordisk - Recombinant Insulin for Enhancing Cell Culture and Protein Production
Recombinant Insulin, commercially known as Insulin Human AF, is an engineered protein made from human insulin crystals, crafted through advanced microbial expression systems in yeast. This product plays a vital role in binding to insulin receptors, which is crucial for triggering key intracellular signaling pathways that govern cellular growth, differentiation, and glucose uptake. It is instrumental in improving cell culture proliferation and enhancing protein yields by facilitating transcription, DNA synthesis, replication, and protein translocation. This insulin variant is critical for the manufacture of monoclonal antibodies, virus vaccines, gene therapy medications, and other biotech innovations approved globally by regulatory authorities. Available in variable packaging sizes, it supports process optimization and high-yield cellular products.
Recombinant Insulin (also known as Insulin human AF) is a recombinant protein consisting of human insulin crystals, a biosynthetic product created using recombinant microbial expression in yeast. As insulin binds to its receptor, it initiates intracellular signalling pathways that regulate cell growth, differentiation, survival and glucose uptake. This promotes cell culture growth and enhances protein yields by modulating transcription, DNA synthesis and replication, and stimulating protein translocation.
Recombinant Insulin is used to produce monoclonal antibodies, virus vaccines, gene therapy drugs, and other innovative biologic products approved for use by regulatory bodies worldwide.